Use of Systemic Sympathetic alpha-1a Antagonist Medication for Treatment of Prostatic Hypertrophy

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1611" ]
    } ]
  },
  "date" : "2017-08-23T01:00:04-04:00",
  "meta" : {
    "versionId" : "20",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "American Academy of Ophthalmology Steward",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: This value set contains concepts that represent systemic sympathetic alpha-1a antagonist medications for treatment of prostatic hypertrophy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; oral administrations of alfuzosin hydrochloride, doxazosin, prazosin, and terazosin.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)",
  "name" : "UseOfSystemicSympatheticAlpha1aAntagonistMedicationForTreatmentOfProstaticHypertrophy",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "197625",
      "display" : "doxazosin 1 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "197626",
      "display" : "doxazosin 2 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "197627",
      "display" : "doxazosin 4 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "197628",
      "display" : "doxazosin 8 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "198141",
      "display" : "prazosin 5 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "199797",
      "display" : "prazosin 1 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "199798",
      "display" : "prazosin 2 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "199799",
      "display" : "prazosin 5 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "260376",
      "display" : "terazosin 10 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "312481",
      "display" : "polythiazide 0.5 MG / prazosin 1 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "312482",
      "display" : "polythiazide 0.5 MG / prazosin 2 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "312483",
      "display" : "polythiazide 0.5 MG / prazosin 5 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "312593",
      "display" : "prazosin 1 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "312594",
      "display" : "prazosin 2 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "313215",
      "display" : "terazosin 1 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "313217",
      "display" : "terazosin 2 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "313219",
      "display" : "terazosin 5 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "636360",
      "display" : "24 HR doxazosin 4 MG Extended Release Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "636361",
      "display" : "24 HR doxazosin 8 MG Extended Release Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "861132",
      "display" : "24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "861402",
      "display" : "phenoxybenzamine hydrochloride 10 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "863669",
      "display" : "tamsulosin hydrochloride 0.4 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "996097",
      "display" : "dutasteride 0.5 MG / tamsulosin hydrochloride 0.4 MG Oral Capsule",
      "version" : "05062024"
    } ],
    "total" : 23,
    "identifier" : "urn:uuid:65cada0e-412b-4746-9d44-b4df56f98a65",
    "timestamp" : "2024-06-14T17:41:42-04:00"
  },
  "title" : "Use of Systemic Sympathetic alpha-1a Antagonist Medication for Treatment of Prostatic Hypertrophy",
  "extension" : [ {
    "valueString" : "American Academy of Ophthalmology Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2024-06-03",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2017-08-23",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "retired",
  "id" : "2.16.840.1.113883.3.526.3.1442",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1442",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.526.3.1442"
  } ],
  "version" : "20170823"
}